media – Page 540 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Smartphone apps to help Queensland mothers from gestational diabetes

Diabetes Australia's (the third oldest diabetes association in the world) latest figures show that over 200,000 women have suffered gestational diabetes during the last 10 years and is expected to exceed 500,000 within the next decade. Gestational diabetes can be fatal if untreated and could likely lead to overweight babies, premature births, as well as PreEclampsia.
- Source: Ddu
- 874
- May 11, 2018
diabetes pregnancy Researches
IoT is bringing a paradigm shift in healthcare

The Internet of Things (IoT) has changed the functionalities of the medical and healthcare sectors and has brought significant changes in the healthcare services delivery model.
- Source: Ddu
- 588
- May 11, 2018
digital health IoT mHealth Researches
Amazon focusing to upend healthcare sector with Alexa

The team is focusing to make Alex, the voice assistant, more convenient and useful in the health-care sector, which requires regulations and data privacy set by the HIPAA – Health Insurance Portability and Accountability Act. The experts are aiming to work on diabetes management, assistance for mother, infants and the elderly.
- Source: Ddu
- 717
- May 11, 2018
Company Insights digital health mHealth
Faron shares almost crashed 90% on Traumakine failure

Finland pharmaceuticals company Faron (AIM: FARN) has crashed almost 90% of its shares, as the company announced the Phase III INTEREST trial of traumakine failed to meet its efficacy endpoint.
- Source: Ddu
- 690
- May 11, 2018
COPD Researches
Handheld device from Israeli startup to let pregnant women take smartphone ultrasound scans

A technology that can change the way women check their baby’s health is in the final stages of development. PulseNmore LTD, an Israeli startup is developing a handheld ultrasound device that can be connected to any smartphone for monitoring the growth of a fetus.
- Source: drugdu
- 726
- May 11, 2018
digital health New Approvals pregnancy
Lodo Therapeutics Corporation Forms Multi-Target Strategic Collaboration with Genentech

Lodo Therapeutics Corporation, a drug discovery and development company focused on identifying and producing unique, bioactive natural products directly from the microbial DNA sequence information contained in soil, today announced that it has formed a strategic drug discovery collaboration with Genentech, a member of the Roche Group.
- Source: pharmalive
- 659
- May 11, 2018
Genentech Roche
Janssen Closes in on Seeking FDA Approval for Ketamine-Based Depression Treatment

Janssen Pharmaceuticals is eying a potential breakthrough in treating refractory major depressive disorder. The company plans to seek regulatory approval for its ketamine-based esketamine nasal spray this year and if given the green light it will be the first new approach for the indication in nearly 50 years.
- Source: biospace
- 587
- May 11, 2018
depressive disorder Janssen
Safer HIV drugs taken off the shelf by Gilead

It has been stated by the patients that Gilead concealed crucial information that the TDF drugs could trigger kidney and bone risks. A safer alternative in the form of TAF could have been incorporated while marketing Truvada and Atripla. The research into TAF was deliberately stopped and the drugs are not likely to be brought to the shelf in the near future.
- Source: drugdu
- 870
- May 11, 2018
Company Insights Gilead HIV
New Ebola outbreak declared in Democratic Republic of the Congo

The Government of the Democratic Republic of the Congo declared a new outbreak of Ebola virus disease (EVD) in Bikoro in Equateur Province today (8 May). The outbreak declaration occurred after laboratory results confirmed two cases of EVD.
- Source: WHO
- 597
- May 10, 2018
Ebola Researches
U.S Doctor trust Biogen and Bristol-Myers Squibb

The questionnaire raised queries on the basis of key parameters like empathy for healthcare providers, quality content and motivation for patients. However, qualities like credible scientific content and values not related to promotional activities emerged as strong criterion for building trust.
- Source: fiercepharma
- 672
- May 10, 2018
digital health Market Views Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.